Advanced Biomedical Technologies P/S 2024

Advanced Biomedical Technologies Aktienanalyse

What does Advanced Biomedical Technologies do?

Advanced Biomedical Technologies Inc is an innovative biomedical company specializing in the development of advanced medical devices and technologies. The company was founded in 1985 by an experienced team of biotech experts and is headquartered in California, USA. History: The company's roots lie in the research and development of novel medical implants and prosthetics. However, over the years, the company has quickly evolved into a leading provider of medical devices and technologies in the fields of diagnostics, therapy, and care. Business model: The business model of Advanced Biomedical Technologies Inc is focused on providing innovative and advanced solutions for medical care. The company strives to continuously develop its products and help customers achieve their healthcare goals. Divisions: The company is divided into four main divisions focusing on different medical areas: 1) Interventional Cardiology: Here, the company develops devices for the treatment of heart diseases, such as stents for reopening narrowed vessels. 2) Orthopedics: Another focus is on the development of innovative orthopedic implants and prosthetics that help patients regain their mobility and improve their quality of life. 3) Oncology: In this division, the company works on the development of medical devices and systems for the diagnosis and treatment of cancer. 4) Neurology: Here, the company focuses on the development of medical technologies and devices for the diagnosis and treatment of nervous system disorders, such as Parkinson's or Alzheimer's. Products: Advanced Biomedical Technologies Inc's products include a variety of medical devices and technologies specialized in different medical areas. Some of the company's most well-known products are: - Stents for reopening narrowed vessels in the heart - Artificial joints and implants for restoring mobility and quality of life - Medical devices for the diagnosis and treatment of cancer - Neurostimulation devices for the treatment of chronic pain and other neurological disorders - Robot-assisted surgery systems that assist surgeons in complex procedures. Conclusion: Advanced Biomedical Technologies Inc is a leading biomedical company specializing in the development of advanced medical devices and technologies. The company has a long history in the research and development of medical implants and prosthetics but has quickly expanded into a broader range of medical applications. With its focus on developing innovative products for patients' quality of life, Advanced Biomedical Technologies Inc will continue to play an important role in medical innovation. Advanced Biomedical Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Advanced Biomedical Technologies's P/S Ratio

Advanced Biomedical Technologies's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Advanced Biomedical Technologies's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Advanced Biomedical Technologies's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Advanced Biomedical Technologies’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Advanced Biomedical Technologies Stock

What is the price-to-earnings ratio of Advanced Biomedical Technologies?

The price-earnings ratio of Advanced Biomedical Technologies is currently 96.21.

How has the price-earnings ratio of Advanced Biomedical Technologies changed compared to last year?

The price-to-earnings ratio of Advanced Biomedical Technologies has increased by 7,984.87% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Advanced Biomedical Technologies high compared to other companies?

Yes, the price-to-earnings ratio of Advanced Biomedical Technologies is high compared to other companies.

How does an increase in the price-earnings ratio of Advanced Biomedical Technologies affect the company?

An increase in the price-earnings ratio of Advanced Biomedical Technologies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Advanced Biomedical Technologies affect the company?

A decrease in the price-earnings ratio of Advanced Biomedical Technologies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Advanced Biomedical Technologies?

Some factors that influence the price-earnings ratio of Advanced Biomedical Technologies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Advanced Biomedical Technologies pay?

Over the past 12 months, Advanced Biomedical Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Advanced Biomedical Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Advanced Biomedical Technologies?

The current dividend yield of Advanced Biomedical Technologies is .

When does Advanced Biomedical Technologies pay dividends?

Advanced Biomedical Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Advanced Biomedical Technologies?

Advanced Biomedical Technologies paid dividends every year for the past 0 years.

What is the dividend of Advanced Biomedical Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Advanced Biomedical Technologies located?

Advanced Biomedical Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanced Biomedical Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanced Biomedical Technologies from 6/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Advanced Biomedical Technologies pay the last dividend?

The last dividend was paid out on 6/6/2024.

What was the dividend of Advanced Biomedical Technologies in the year 2023?

In the year 2023, Advanced Biomedical Technologies distributed 0 USD as dividends.

In which currency does Advanced Biomedical Technologies pay out the dividend?

The dividends of Advanced Biomedical Technologies are distributed in USD.